, /PRNewswire/ -- (Nasdaq: ESRX) announced today its intention to release its 2016 financial guidance on , via press release before the market opens and prior to a conference call to discuss the 2016 financial guidance on , at (). The conference call will feature remarks by , CEO and chairman, , President and , CFO.

'With integration activities firmly behind us and the continued improvement in our budgeting process, our leadership team is pleased to announce an accelerated schedule to provide 2016 financial guidance,' said , Chief Financial Officer. 'We look forward to sharing our outlook before the start of the New Year.'

The call is being webcast and can be accessed at the Investor Information section of web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.

Following the conference call, the webcast will remain available on the Investor Information section of website for 14 days.

About

puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in , provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/express-scripts-holding-company-announces-2016-financial-guidance-webcast-and-conference-call-300192586.html

SOURCE

Eric Slusser, Chief Financial Officer; or Ben Bier, Vice President Investor Relations, (314) 810-3115, investor.relations@express-scripts.com

distributed by